"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.

Bloomberg Businessweek Weekend - March 13th, 2026
41:18

Judge Rejects Subpoenas of Fed Board in Powell Case
38:43

Private Credit’s ‘Back Leverage’ Is Another Pain Point for Funds
10:47